• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Comprehensive Overview of tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate (CAS No. 117565-57-8)

tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate (CAS No. 117565-57-8) is a specialized organic compound widely utilized in pharmaceutical and chemical research. This piperidine derivative is particularly valued for its role as an intermediate in the synthesis of bioactive molecules. The compound's unique structure, featuring a tert-butyl group and a 4-oxo-piperidine core, makes it a versatile building block in medicinal chemistry. Researchers often explore its applications in drug discovery, especially in the development of central nervous system (CNS) therapeutics and enzyme inhibitors.

In recent years, the demand for tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate has surged due to its relevance in addressing modern healthcare challenges. For instance, its potential role in targeting neurodegenerative diseases like Alzheimer's and Parkinson's has garnered significant attention. The compound's ability to modulate specific biochemical pathways aligns with the growing focus on precision medicine. Additionally, its applications in peptide synthesis and protease inhibitor development have made it a subject of interest in both academic and industrial settings.

The synthesis of tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate involves multi-step organic reactions, often starting from readily available precursors. Key steps include the introduction of the 3-ethyl substituent and the formation of the 4-oxo (ketone) functionality. The tert-butyloxycarbonyl (Boc) protecting group is a critical feature, ensuring stability during subsequent reactions. This compound's purity and yield are meticulously controlled, as they directly impact its efficacy in downstream applications. Analytical techniques such as HPLC, NMR, and mass spectrometry are routinely employed for quality assurance.

From an industrial perspective, tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate is often sourced from specialized chemical suppliers who adhere to stringent regulatory standards. Its storage and handling require attention to moisture sensitivity and temperature control to maintain integrity. The compound's compatibility with various solvents, including dichloromethane and tetrahydrofuran, further enhances its utility in diverse synthetic protocols. As sustainability becomes a priority, researchers are also exploring greener synthesis routes for this intermediate.

The scientific community continues to investigate novel derivatives of tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate to expand its therapeutic potential. For example, modifications to the ethyl side chain or the piperidine ring have yielded compounds with enhanced bioavailability and selectivity. Such innovations are particularly relevant in the context of personalized medicine, where tailored molecular designs are essential. Furthermore, computational chemistry tools are increasingly used to predict the compound's interactions with biological targets, accelerating drug discovery workflows.

In summary, tert-butyl 3-ethyl-4-oxo-piperidine-1-carboxylate (CAS No. 117565-57-8) represents a critical tool in modern chemical and pharmaceutical research. Its structural features and functional groups enable diverse applications, from CNS drug development to enzyme inhibition. As the demand for innovative therapeutics grows, this compound is poised to remain at the forefront of scientific exploration. Future advancements in synthetic methodologies and target-specific modifications will likely further elevate its significance in the field.

• 277298-22-3(tert-Butyl 4-Oxo-3-propylpiperidine-1-carboxylate)
• 858643-92-2(Tert-butyl 3-acetylpiperidine-1-carboxylate)
• 1008563-06-1((S)-1-Boc-3-acetyl-piperidine)
• 512822-20-7(10-Oxo-8-aza-bicyclo[4.3.1]decane-8-carboxylic acid tert-butyl ester)
• 1700136-35-1(TERT-BUTYL 3-(2-METHYLPROPYL)-4-OXOPIPERIDINE-1-CARBOXYLATE)
• 942143-25-1(tert-butyl (3R)-3-acetylpiperidine-1-carboxylate)
• 267230-34-2(1-Piperidinecarboxylic acid,3-[[(3S)-3-(ethoxycarbonyl)-1-piperidinyl]carbonyl]-, 1,1-dimethylethylester, (3R)-)
• 1196151-56-0(tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate)
• 1226294-61-6(tert-Butyl 3-propionylpiperidine-1-carboxylate)
• 512822-34-3(Tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate)